The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Mesenchymal stem cell therapy for knee osteoarthritis: 5 years follow‐up of three patients
Open accessAbstract
Aim: Osteoarthritis is a degenerative joint disease characterized by the destruction of joint cartilage. Mesenchymal stem cells (MSC s) are found in low numbers in normal cartilage, mainly in the superficial layer, acting as repairing agents. In OA, MSC s are seen in larger numbers, but act chaotic and are unable to repair the cartilage. The synovial membrane becomes inflamed and interacts with the cartilage. Transplanted MSC have the ability to normalize them, redirecting them to their normal function. In a preliminary study, we showed that MSC could improve knee OA in four patients at 6 months. This report shows their long‐term follow‐up at 5 years. Methods: One patient was lost to follow‐up at 2 years and three were followed for 5 years. They were aged 55, 57, 65 and 54 years, and had moderate to severe knee osteoarthritis. The worse knee of each patient was injected with 8–9 × 10 6 MSC. Results: As previously reported, all parameters improved in transplant knees at 6 months (walking time, stair climbing, gelling pain, patella crepitus, flection contracture and the visual analogue score on pain). Then, they started gradually to deteriorate, but at 5 years they were still better than at baseline. PGA (Patient Global Assessment) improved from baseline to 5 years. The better knee at baseline (no MSC), continued its progression toward aggravation and at 5 years became the worse knee. Conclusion: Transplant knees were all in a rather advanced stage of OA. Earlier transplantation may give better results in long‐term follow‐up. This is what future studies have to demonstrate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of proinflammatory cytokines in the pathophysiology of osteoarthritis
Kapoor, M., Martel-Pelletier, J., Lajeunesse, D., Pelletier, J.-P., & Fahmi, H. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.196 · Cited by 2,778
Cited by
Recent Updates of Diagnosis, Pathophysiology, and Treatment on Osteoarthritis of the Knee
Jang, S., Lee, K., & Ju, J. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052619 · Cited by 803
Giorgino, R., Albano, D., Fusco, S., Peretti, G. M., Mangiavini, L., & Messina, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076405 · Cited by 387
Mesenchymal stem cell-based therapy of osteoarthritis: Current knowledge and future perspectives
Harrell, C. R., Markovic, B. S., Fellabaum, C., Arsenijevic, A., & Volarevic, V. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.099 · Cited by 301
Mesenchymal stem cell-derived exosomes: a new therapeutic approach to osteoarthritis?
Mianehsaz, E., Mirzaei, H. R., Mahjoubin-Tehran, M., Rezaee, A., Sahebnasagh, R., Pourhanifeh, M. H., Mirzaei, H., & Hamblin, M. R. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1445-0 · Cited by 274
Prakash, N., Kim, J., Jeon, J., Kim, S., Arai, Y., Bello, A. B., Park, H., & Lee, S.-H. (2023) · Biomaterials Research · doi:10.1186/s40824-023-00371-0 · Cited by 56
Metadata
- Authors
- Davatchi, F., Sadeghi Abdollahi, B., Mohyeddin, M., & Nikbin, B.
- Venue
- International Journal of Rheumatic Diseases
- Publisher
- Wiley
- Published
- 2015-05-20
- Volume
- 19
- Issue
- 3
- Pages
- 219-225
- ISSN
- 1756-1841 (ISSN-L)
- 1756-185X
- OpenAlex
- W1790126255
- Cited by
- 199
- References
- 1
- FWCI
- 13.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mesenchymal stem cell therapy for knee osteoarthritis: 5 years follow‐up of three patients. https://app.cochat.ai/papers/10.1111/1756-185x.12670
- The paper
- Davatchi, F., Sadeghi Abdollahi, B., Mohyeddin, M., & Nikbin, B. (2016). Mesenchymal stem cell therapy for knee osteoarthritis: 5 years follow‐up of three patients. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.12670
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.